CCEL
CryoCell International Inc
4.00$
+1.0%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 27.4% | 26.4% | 26.3% | 25.2% | 26.4% | 20.4% | 24.9% | 23.4% | 23.0% | 22.1% | 21.6% | 23.9% | 22.7% | |
| 72.6% | 73.6% | 73.7% | 74.8% | 73.6% | 79.6% | 75.1% | 76.6% | 77.0% | 77.9% | 78.4% | 76.1% | 77.3% | |
| 4.4% | 5.6% | 6.4% | 3.0% | 2.4% | 3.8% | 1.2% | 1.7% | 0.8% | 1.1% | 0.9% | 1.3% | 1.0% | |
| 48.3% | 68.5% | 55.3% | 50.0% | 51.4% | 74.9% | 58.2% | 53.7% | – | 54.3% | 65.2% | 59.4% | – | |
| 57.8% | 279.0% | 63.2% | 57.5% | 56.4% | 81.1% | 61.8% | 57.8% | 52.7% | 128.5% | 68.5% | 60.7% | 77.7% | |
| 14.8% | -205.4% | 10.5% | 17.3% | 17.2% | -1.5% | 13.3% | 18.8% | 24.3% | -50.6% | 10.0% | 15.4% | -0.3% | |
| 6.0% | 2.1% | 3.3% | 4.1% | 6.6% | 9.3% | 6.2% | 7.0% | 6.9% | 6.1% | 6.0% | 5.7% | 6.2% | |
| 13.6% | -203.0% | 10.1% | 18.3% | 17.1% | -10.5% | 6.7% | 7.3% | 15.2% | -59.1% | 0.9% | 10.6% | -8.2% | |
| 4.9% | -61.0% | 3.0% | 10.2% | 4.1% | 12.7% | 3.1% | 2.8% | -5.6% | 0.7% | 0.3% | 3.5% | -0.3% | |
| 8.6% | -142.1% | 7.1% | 8.2% | 13.0% | -23.2% | 3.5% | 4.5% | 20.7% | -59.8% | 0.6% | 7.1% | -7.9% | |
| 24.9% | -200.0% | 15.4% | 24.7% | -18.4% | 3.0% | 17.2% | 20.5% | 24.4% | -48.7% | 11.4% | 20.7% | 1.9% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.